PICALM rs3851179: Understanding Alzheimer's Disease Risk Markers
The rs3851179 variant is a well-replicated genetic marker located near the PICALM gene. It is widely studied for its statistical association with the risk of developing late-onset Alzheimer's disease.
What each genotype means
Typical risk profile
You carry two copies of the G allele, which is the baseline and more common allele at this locus. Genome-wide association studies link this genotype to average baseline population odds for late-onset Alzheimer disease relative to this single marker. This common variant only accounts for a very small change in statistical risk and does not determine whether an individual will develop cognitive decline.
Found in approximately 35% to 45% of individuals of European ancestry and is the predominant genotype across most global populations.
Slightly reduced risk profile
You carry one copy of the protective A allele near the PICALM gene. Large-scale genetic studies associate each copy of the A allele with a subtle reduction in relative risk for late-onset Alzheimer disease compared to the standard background. Because Alzheimer disease is multifactorial, this variant confers only modest statistical odds modulation alongside lifestyle and other genetic factors.
Carried by approximately 45% to 50% of individuals of European ancestry.
Moderately reduced risk profile
You carry two copies of the protective A allele near the PICALM gene. In population-level studies, carrying two copies of this allele is statistically associated with a modest decrease in the relative likelihood of developing late-onset Alzheimer disease. However, this marker alone is not diagnostic or fully protective, and overall cognitive health depends on numerous genetic, vascular, and lifestyle factors.
Carried by roughly 12% to 16% of individuals of European ancestry; it occurs at lower frequencies in African and East Asian populations.
What is the rs3851179 Variant?
The rs3851179 variant is a single nucleotide polymorphism (SNP) located in the vicinity of the PICALM gene on chromosome 11. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific marker has been identified through genome-wide association studies (GWAS) as a significant locus linked to late-onset Alzheimer's disease (LOAD). While the variant itself does not cause the disease, its presence is statistically correlated with an altered risk profile. Researchers often use such markers to better understand the complex genetic architecture of neurodegenerative conditions. Because this variant sits in a non-coding region near the gene, it is thought to influence how the PICALM gene is regulated or expressed rather than changing the structure of the protein itself.
The Role of the PICALM Gene
The PICALM gene encodes the phosphatidylinositol-binding clathrin assembly protein. This protein plays a critical role in clathrin-mediated endocytosis, a fundamental cellular process that allows cells to internalize molecules from their environment. In the brain, this process is essential for synaptic transmission and the regulation of amyloid-beta protein precursor trafficking. Recent research indicates that PICALM is particularly important for the function of microglia, the brain's primary immune cells. When PICALM expression is reduced, microglia may struggle to clear cellular debris, leading to an accumulation of lipids and cholesterol. This impairment in the brain's waste-clearance system is a subject of intense investigation, as it may contribute to the neurodegenerative processes observed in Alzheimer's disease.
Research and Evidence Strength
The association between rs3851179 and late-onset Alzheimer's disease is considered well-replicated across multiple large-scale studies. Since its initial identification in 2009, numerous meta-analyses and follow-up studies have confirmed that this locus contributes to the genetic risk of the disease. However, it is important to note that the individual effect size of this variant is relatively small compared to major risk factors like APOE. While the statistical evidence for an association is strong, the biological mechanism is still being elucidated. Current research focuses on how the variant influences PICALM protein levels and subsequent microglial health. Because Alzheimer's is a multifactorial condition influenced by many genes and environmental factors, this variant should be viewed as one piece of a much larger, ongoing scientific puzzle.
What This Information Means for You
Genetic information regarding variants like rs3851179 is primarily used for research purposes to understand disease mechanisms. It is not a diagnostic tool, and the presence of a specific genotype does not predict whether an individual will develop Alzheimer's disease. Many people with the 'risk' allele never develop the condition, and many without it do. If you are concerned about your cognitive health or family history, the most effective approach is to consult with a healthcare professional or a genetic counselor. They can provide context based on your personal medical history and current clinical guidelines. Avoid making health decisions based solely on direct-to-consumer genetic reports, as these markers are only small contributors to overall risk and do not account for lifestyle, environment, or other genetic factors.
How common is this variant?
The minor allele (A) of rs3851179 has a frequency of approximately 35-40% across European populations.
Frequently asked questions
Does having the rs3851179 variant mean I will get Alzheimer's?
No. This variant is a statistical risk marker identified in large population studies, not a diagnostic test. It does not determine your future health outcomes.
What is the difference between the major and minor alleles of PICALM?
The major allele (G) and minor allele (A) refer to the frequency of the DNA base found at this position. Research suggests the minor allele may be associated with a protective effect or altered protein expression in microglia.
Should I get tested for this variant?
Clinical testing for this specific SNP is not standard practice for Alzheimer's diagnosis. If you have concerns about memory or cognitive decline, please speak with a neurologist or primary care physician.
How does PICALM affect the brain?
PICALM is involved in endocytosis, which helps cells manage internal and external materials. In the brain, it supports microglial function, which is necessary for clearing debris and maintaining a healthy environment.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3851681?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29